Yıl: 2023 Cilt: 39 Sayı: 1 Sayfa Aralığı: 35 - 40 Metin Dili: İngilizce DOI: 10.30733/std.2023.01575 İndeks Tarihi: 05-05-2023

Relationship between Juvenile Myoclonic Epilepsy and Melatonin

Öz:
Aim: Melatonin has been found to have anticonvulsant and neuroprotective properties by regulating the circadian rhythm. Based on this effect, it was aimed to determine the serum levels of melatonin in patients with juvenile myoclonic epilepsy (JME) and healthy individuals. It is also the first study to compare serum melatonin levels in patients with JME and healthy individuals. Patients and Methods: Thirty patients with JME and 30 healthy controls with similar gender and age distribution were included in this cross-sectional study. Venous blood samples were taken from patients with JME and healthy individuals to determine the peak serum melatonin level at night and the lowest serum melatonin level in the morning, and studied with the ELIS A method. Results: Compared to healthy controls, serum MELn (p = 0.002) and MELm (p = 0.001) levels of JME patients were determined to be lower than healthy controls. Moreover, there were statistically significant differences between MELn/MELm ratio and MELn-MELm difference between patients with JME and the control group (p = 0.005 and 0.014, respectively). Conclusion: The results show that the circadian rhythm of melatonin is preserved in the patients with JME and the control group, but the serum melatonin levels in the patients are lower than in the controls. Therefore, the determination of melatonin level in patients with JME may contribute to both the determination of the etiology of the disease and the prevention of unnecessary and high-dose antiepileptic drug use by supplementing with melatonin when necessary .
Anahtar Kelime:

Juvenil Miyoklonik Epilepsi ve Melatonin İlişkisi

Öz:
Amaç: Melatoninin sirkadiyen ritmi düzenleyerek antikonvülsan ve nöroprotektif özelliklere sahip olduğu bulunmuştur. Bu etkisinden yola çıkarak Juvenil myoklonik epilepsili (JME) hastalar ve sağlıklı bireylerde melatonin serum düzeylerinin belirlenmesi amaçlanmıştır. JME’li hastalar ile sağlıklı bireylerdeki serum melatonin seviyelerini karşılaştıran ilk çalışma olma özelliğin i de taşımaktadır . Hastalar ve Yöntem: Bu çapraz-kesitsel çalışmaya JME’li 30 hasta ve benzer cinsiyet ve yaş dağılımına sahip 30 sağlıklı kontrol dahil edildi. JME’li hastalar ve sağlıklı bireylerden, gece meydana gelen serum melatonin pik düzeyini ve sabahki en düşük serum melatonin düzeyini belirlemek üzere venöz kan örnekleri alınarak ELISA yöntemiyle çalışıldı. Bulgular: Sağlıklı kontrollere kıyasla JME'li hastaların serum MELn (p = 0,002) ve MELm (p = 0,001) düzeyi daha düşük tespit edildi. Ayrıca JME’li hastalar ve kontrol grubu arasında MELn/MELm oranı ve MELn-MELm farkı açısından istatistiksel olarak anlamlı farklılıklar vardı (sırasıyla p = 0,005 ve 0,014). Sonuç: Elde edilen sonuçlar JME’li hastalar ve kontrol grubunda melatoninin sirkadien ritminin korunduğunu fakat hastalarda serum melatonin düzeylerinin kontrollere göre düşük seyrettiğini göstermektedir. Bundan dolayı JME’li hastalarda melatonin düzeyinin tespiti hem hastalık etyolojisinin belirlenmesine hem de gerektiğinde melatonin takviyesi yapılması ile gereksiz ve yüksek doz antiepileptik ilaç kullanımının engellenmesine katkı sağlayabilir .
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International league against epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58:522-30.
  • 2. Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia 2005;46 Suppl 9:48-56.
  • 3. Kim KY, Moon JU, Lee JY, et al. Distributed source localization of epileptiform discharges in juvenile myoclonic epilepsy: Standardized low-resolution brain electromagnetic tomography (sLORETA) Study. Medicine (Baltimore) 2022;101:e29625.
  • 4. Lin CY, Wu T, Chang CW, et al. Reduced sleep quality is related to poor quality of life in patients with juvenile myoclonic epilepsy, a case-control study. Life (Basel) 2022;12:434.
  • 5. Kleveland G, Engelsen BA. Juvenile myoclonic epilepsy: Clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure 1998;7:31-8.
  • 6. Syvertsen MR , Markhus R, Selmer KK, et al. Juvenile myoclonic epilepsy. Tidsskr Nor Laegeforen 2012;132:1610- 3.
  • 7. Samanta S. Physiological and pharmacological perspectives of melatonin. Arch Physiol Biochem 2020:1-22.
  • 8. Singh M, Jadhav HR. Melatonin: Functions and ligands Drug Discov Today 2014;19:1410-8.
  • 9. Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335-53.
  • 10. Vasileva Z. Melatonin and Epilepsy. Folia Med (Plovdiv) 2021;63:827-33.
  • 11. Quigg M. Circadian rhythms: Interactions with seizures and epilepsy. Epilepsy Res 2000;42:43-55.
  • 12. Lynch HJ, Wurtman RJ, Moskowitz MA, et al. Daily rhythm in human urinary melatonin. Science 1975;187:169-71.
  • 13. Anderson G, Maes M. Interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in central nervous system and psychiatric disorders: Role of the aryl hydrocarbon receptor and direct mitochondria regulation. Int J Tryptophan Res 2017;10:1178646917691738.
  • 14. Lu J, Luo Y, Mei S, et al. The effect of melatonin modulation of mon-coding RNAs on central nervous system disorders: An updated review. Curr Neuropharmacol 2021;19:3-23.
  • 15. Mahyar A, Ayazi P, Dalirani R, et al. Melatonin's effect in febrile seizures and epilepsy. Iran J Child Neurol 2014;8:24- 9.
  • 16. Yalin O, Arman F, Erdogan F, et al. A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures. Epilepsy Behav 2006;8:542-6.
  • 17. Fauteck J, Schmidt H, Lerchl A, et al. Melatonin in epilepsy: First results of replacement therapy and first clinical results. Biol Signals Recept 1999;8:105-10.
  • 18. Ross C, Davies P, Whitehouse W. Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: An observational study. Dev Med Child Neurol 2002;44:339-44.
  • 19. Petkova Z, Tchekalarova J, Pechlivanova D, et al. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy. Epilepsy Behav 2014;31:198-208.
  • 20. Molina-Carballo A, Muñoz-Hoyos A, Reiter RJ, et al. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: Two years' experience. J Pineal Res 1997 ;23:97-105.
  • 21. Guo JF, Yao BZ. Serum melatonin levels in children with epilepsy or febrile seizures. Zhongguo Dang Dai Er Ke Za Zhi 2009;11:288-90.
  • 22. Bazil CW, Short D, Crispin D, et al. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology 2000;55:1746-8.
  • 23. Molina-Carballo A, Muñoz-Hoyos A, Sánchez-Forte M, et al. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations. Neuropediatrics 2007;38:122-5.
  • 24. Schapel GJ, Beran RG, Kennaway DL, et al. Melatonin response in active epilepsy. Epilepsia 1995;36:75-8.
  • 25. Rao ML, Stefan H, Bauer J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 1989;49:33-9.
  • 26. Kasteleijn-Nolst Trenité DG, de Weerd A, Beniczky S. Chronodependency and provocative factors in juvenile myoclonic epilepsy. Epilepsy Behav 2013;28 Suppl 1:S25-9.
APA Altaş M, GENÇ B, KILINC I, Akyol A (2023). Relationship between Juvenile Myoclonic Epilepsy and Melatonin. , 35 - 40. 10.30733/std.2023.01575
Chicago Altaş Mustafa,GENÇ BÜLENT OGUZ,KILINC Ibrahim,Akyol Asli Relationship between Juvenile Myoclonic Epilepsy and Melatonin. (2023): 35 - 40. 10.30733/std.2023.01575
MLA Altaş Mustafa,GENÇ BÜLENT OGUZ,KILINC Ibrahim,Akyol Asli Relationship between Juvenile Myoclonic Epilepsy and Melatonin. , 2023, ss.35 - 40. 10.30733/std.2023.01575
AMA Altaş M,GENÇ B,KILINC I,Akyol A Relationship between Juvenile Myoclonic Epilepsy and Melatonin. . 2023; 35 - 40. 10.30733/std.2023.01575
Vancouver Altaş M,GENÇ B,KILINC I,Akyol A Relationship between Juvenile Myoclonic Epilepsy and Melatonin. . 2023; 35 - 40. 10.30733/std.2023.01575
IEEE Altaş M,GENÇ B,KILINC I,Akyol A "Relationship between Juvenile Myoclonic Epilepsy and Melatonin." , ss.35 - 40, 2023. 10.30733/std.2023.01575
ISNAD Altaş, Mustafa vd. "Relationship between Juvenile Myoclonic Epilepsy and Melatonin". (2023), 35-40. https://doi.org/10.30733/std.2023.01575
APA Altaş M, GENÇ B, KILINC I, Akyol A (2023). Relationship between Juvenile Myoclonic Epilepsy and Melatonin. Selçuk Tıp Dergisi, 39(1), 35 - 40. 10.30733/std.2023.01575
Chicago Altaş Mustafa,GENÇ BÜLENT OGUZ,KILINC Ibrahim,Akyol Asli Relationship between Juvenile Myoclonic Epilepsy and Melatonin. Selçuk Tıp Dergisi 39, no.1 (2023): 35 - 40. 10.30733/std.2023.01575
MLA Altaş Mustafa,GENÇ BÜLENT OGUZ,KILINC Ibrahim,Akyol Asli Relationship between Juvenile Myoclonic Epilepsy and Melatonin. Selçuk Tıp Dergisi, vol.39, no.1, 2023, ss.35 - 40. 10.30733/std.2023.01575
AMA Altaş M,GENÇ B,KILINC I,Akyol A Relationship between Juvenile Myoclonic Epilepsy and Melatonin. Selçuk Tıp Dergisi. 2023; 39(1): 35 - 40. 10.30733/std.2023.01575
Vancouver Altaş M,GENÇ B,KILINC I,Akyol A Relationship between Juvenile Myoclonic Epilepsy and Melatonin. Selçuk Tıp Dergisi. 2023; 39(1): 35 - 40. 10.30733/std.2023.01575
IEEE Altaş M,GENÇ B,KILINC I,Akyol A "Relationship between Juvenile Myoclonic Epilepsy and Melatonin." Selçuk Tıp Dergisi, 39, ss.35 - 40, 2023. 10.30733/std.2023.01575
ISNAD Altaş, Mustafa vd. "Relationship between Juvenile Myoclonic Epilepsy and Melatonin". Selçuk Tıp Dergisi 39/1 (2023), 35-40. https://doi.org/10.30733/std.2023.01575